Total Funding
27
Total FundingSeries C raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
51492
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
- Gaddy Getz: Founder
- Axel Hoos: CEOPast Role: GSK, Senior Vice President, Therapeutic Area Head
About the Company
Scorpion Therapeutics is a clinical-stage oncology company specializing in precision medicine for cancer patients. It develops targeted small-molecule drugs to interact with validated cancer targets. It aims to leverage its platform to advance a broad pipeline of wholly-owned, optimized compounds across molecules targeting validated oncogene
targets, molecules for previously undruggable targets, and molecules for novel cancer targets.
